Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Leach

Showing results (61-70 of 216) with videos related to

Pageof 22
Sort By:
Journal of Gastroenterology and Hepatology|February 14, 2009
Defensins and inflammation: the role of defensins in inflammatory bowel diseaseMalith Ramasundara, Steven T Leach, Daniel A Lemberg, et al.
Journal of Paediatrics and Child Health|April 5, 2014
Low rate of inflammatory bowel disease in the Australian indigenous paediatric populationSteven T Leach, Andrew S Day, David Moore, et al.
Digestive Diseases and Sciences|September 20, 2013
Osteoprotegerin exerts its pro-inflammatory effects through nuclear factor-κB activationLily Nahidi, Steven T Leach, Daniel A Lemberg, et al.
Digestive Diseases and Sciences|June 28, 2012
Fecal M2-PK in children with Crohn's disease: a preliminary reportA S Day, T Judd, D A Lemberg, et al.
The Journal of Infectious Diseases|July 9, 1999
The epidemiology of viral hepatitis in children in South Texas: increased prevalence of hepatitis A along the Texas-Mexico borderC T Leach, F C Koo, S G Hilsenbeck, et al.
Mechanisms of Ageing and Development|September 1, 2004
Human chromosomes with shorter telomeres and large heterochromatin regions have a higher frequency of acquired somatic cell aneuploidyNatalia T Leach, Catherine Rehder, Keith Jensen, et al.
Journal of Gastroenterology|June 16, 2012
An update of the role of nutritional therapy in the management of Crohn's diseaseMoftah H Alhagamhmad, Andrew S Day, Daniel A Lemberg, et al.
Frontiers in Pediatrics|February 7, 2018
The Value of Fecal Markers in Predicting Relapse in Inflammatory Bowel DiseasesBianca J Galgut, Daniel A Lemberg, Andrew S Day, et al.
Intractable & Rare Diseases Research|January 22, 2015
Modeling fragile X syndrome in the Fmr1 knockout mouseTatiana M Kazdoba, Prescott T Leach, Jill L Silverman, et al.
Infection and Immunity|September 9, 2020
Presence of Gastric Pepsinogen in the Trachea Is Associated with Altered Inflammation and Microbial CompositionUsha Krishnan, Harveen Singh, Nicodemus Tedla, et al.
Pageof 22

Showing results (61-70 of 216) with videos related to

Sort By:
Pageof 22
Journal of Gastroenterology and Hepatology|February 14, 2009
Defensins and inflammation: the role of defensins in inflammatory bowel diseaseMalith Ramasundara, Steven T Leach, Daniel A Lemberg, et al.
Journal of Paediatrics and Child Health|April 5, 2014
Low rate of inflammatory bowel disease in the Australian indigenous paediatric populationSteven T Leach, Andrew S Day, David Moore, et al.
Digestive Diseases and Sciences|September 20, 2013
Osteoprotegerin exerts its pro-inflammatory effects through nuclear factor-κB activationLily Nahidi, Steven T Leach, Daniel A Lemberg, et al.
Digestive Diseases and Sciences|June 28, 2012
Fecal M2-PK in children with Crohn's disease: a preliminary reportA S Day, T Judd, D A Lemberg, et al.
The Journal of Infectious Diseases|July 9, 1999
The epidemiology of viral hepatitis in children in South Texas: increased prevalence of hepatitis A along the Texas-Mexico borderC T Leach, F C Koo, S G Hilsenbeck, et al.
Mechanisms of Ageing and Development|September 1, 2004
Human chromosomes with shorter telomeres and large heterochromatin regions have a higher frequency of acquired somatic cell aneuploidyNatalia T Leach, Catherine Rehder, Keith Jensen, et al.
Journal of Gastroenterology|June 16, 2012
An update of the role of nutritional therapy in the management of Crohn's diseaseMoftah H Alhagamhmad, Andrew S Day, Daniel A Lemberg, et al.
Frontiers in Pediatrics|February 7, 2018
The Value of Fecal Markers in Predicting Relapse in Inflammatory Bowel DiseasesBianca J Galgut, Daniel A Lemberg, Andrew S Day, et al.
Intractable & Rare Diseases Research|January 22, 2015
Modeling fragile X syndrome in the Fmr1 knockout mouseTatiana M Kazdoba, Prescott T Leach, Jill L Silverman, et al.
Infection and Immunity|September 9, 2020
Presence of Gastric Pepsinogen in the Trachea Is Associated with Altered Inflammation and Microbial CompositionUsha Krishnan, Harveen Singh, Nicodemus Tedla, et al.
Pageof 22